Latest News & Features
Americas
Jazz Pharmaceuticals has sued Watson Laboratories for patent infringement in order to stop the company making a generic version of its flagship product Xyrem. 30 June 2015
Americas
The US Court of Appeals for the Third Circuit has ruled that so-called ‘pay-for-delay’ settlements do not need to involve cash payments to be considered anticompetitive. 29 June 2015
Americas
The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta would be infringed by a product proposed by Actavis, now Allergan. 29 June 2015
Americas
Law firm Andrews Kurth has hired litigation attorney Matthew Dowd as a partner in its Washington, DC office. 26 June 2015
Americas
The Life Sciences Law Forum opened today, June 25, with a lively panel on the implications of online technology for innovative companies in the sector, including the knock on effect for intellectual property rights. 25 June 2015
Americas
A group of individuals has reportedly launched a class action lawsuit against Novartis to stop it enforcing a so-called ‘pay-for-delay’ settlement agreement with generic drug maker Sun Pharma centring on leukaemia drug Gleevec. 25 June 2015
Americas
US law firm Nutter McClennen & Fish has boosted its intellectual property team in Boston with the appointment of Patrick Concannon as partner. 24 June 2015
Americas
The US Food and Drug Administration, along with international police organization Interpol, has targeted more than 1,000 websites that sell fake, unapproved medicines and medical devices. 24 June 2015
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court ruling which said that a reissue patent covering Pfizer’s arthritis drug Celebrex was invalid for obviousness-type double patenting. 24 June 2015
Asia-Pacific
China’s State Intellectual Property Office has rejected Gilead Sciences’s patent application covering its Sovaldi (sofosbuvir) drug after it was challenged by a non-profit group. 23 June 2015